A carregar...
一代与二代酪氨酸激酶抑制剂联合化疗序贯异基因造血干细胞移植治疗Ph(+)急性淋巴细胞白血病疗效比较
OBJECTIVE: To investigate the efficacy of sequential treatment with first-line administration of second-generation tyrosine kinase inhibitors (TKI) and first-generation TKI (imatinib) in patients with Ph(+) acute lymphoblastic leukemia (Ph(+) ALL) followed by allogeneic hematopoietic stem cell trans...
Na minha lista:
| Publicado no: | Zhonghua Xue Ye Xue Za Zhi |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Editorial office of Chinese Journal of Hematology
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7342571/ https://ncbi.nlm.nih.gov/pubmed/29562444 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3760/cma.j.issn.0253-2727.2018.02.007 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|